Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eman E Ahmed

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Ocular Immunology and Inflammation|December 22, 2023
Demographic and Clinical Characteristics of Uveitis for Adult Patients Attending Mansoura Ophthalmic CenterEman E Ahmed, Eglal M El Saeid, Hanem M Kishk, et al.
The Egyptian Journal of Immunology|January 16, 2024
Impact of serum IL 10 on prediction of early allograft rejection in liver transplantationMai A El-Deeb, Ashraf Okba, Mahmoud El-Meteini, et al.
The Egyptian Journal of Immunology|August 28, 2021
Low frequency of CD4+CD25highFOXP3+ T regulatory cells in Egyptian patients with chronic spontaneous urticariaMohamed A Elshayeb, Mohamed N Farres, Nermine Ae Melek, et al.
Clinical Genitourinary Cancer|June 22, 2026
Longitudinal Tumor Mutation Burden Dynamics in Advanced Prostate Cancer Using Circulating Tumor DNA ProfilingNancy Wei, Jamie J O'Byrne, Miguel Muniz, et al.
EJNMMI Research|March 9, 2026
Predictive value of interim ¹¹C-choline PET/CT for response to radium-223 in metastatic castration-resistant prostate cancerEman E Ahmed, Jack R Andrews, Mohamed E Ahmed, et al.
Cancers|March 14, 2026
PSA Zero Radiographic Disease Progression on PSMA PET/CTAhmed M Mahmoud, Carter Day, Eman E Ahmed, et al.
Urologic Oncology|May 21, 2026
Salvage lymph node dissection in oligo-recurrent prostate cancer patients: Mapping patterns of recurrence and factors associated with disease progressionMohamed E Ahmed, Eman E Ahmed, Milad Bonakdarhashemi, et al.
The Prostate|June 8, 2026
Outcomes of Patients With Favorable Intermediate Risk Gleason Grade Group 2 Prostate Cancer Undergoing Radical Prostatectomy in the MRI Era: Refining Active Surveillance Selection CriteriaEric V Li, Eman E Ahmed, Mohamed E Ahmed, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Ocular Immunology and Inflammation|December 22, 2023
Demographic and Clinical Characteristics of Uveitis for Adult Patients Attending Mansoura Ophthalmic CenterEman E Ahmed, Eglal M El Saeid, Hanem M Kishk, et al.
The Egyptian Journal of Immunology|January 16, 2024
Impact of serum IL 10 on prediction of early allograft rejection in liver transplantationMai A El-Deeb, Ashraf Okba, Mahmoud El-Meteini, et al.
The Egyptian Journal of Immunology|August 28, 2021
Low frequency of CD4+CD25highFOXP3+ T regulatory cells in Egyptian patients with chronic spontaneous urticariaMohamed A Elshayeb, Mohamed N Farres, Nermine Ae Melek, et al.
Clinical Genitourinary Cancer|June 22, 2026
Longitudinal Tumor Mutation Burden Dynamics in Advanced Prostate Cancer Using Circulating Tumor DNA ProfilingNancy Wei, Jamie J O'Byrne, Miguel Muniz, et al.
EJNMMI Research|March 9, 2026
Predictive value of interim ¹¹C-choline PET/CT for response to radium-223 in metastatic castration-resistant prostate cancerEman E Ahmed, Jack R Andrews, Mohamed E Ahmed, et al.
Cancers|March 14, 2026
PSA Zero Radiographic Disease Progression on PSMA PET/CTAhmed M Mahmoud, Carter Day, Eman E Ahmed, et al.
Urologic Oncology|May 21, 2026
Salvage lymph node dissection in oligo-recurrent prostate cancer patients: Mapping patterns of recurrence and factors associated with disease progressionMohamed E Ahmed, Eman E Ahmed, Milad Bonakdarhashemi, et al.
The Prostate|June 8, 2026
Outcomes of Patients With Favorable Intermediate Risk Gleason Grade Group 2 Prostate Cancer Undergoing Radical Prostatectomy in the MRI Era: Refining Active Surveillance Selection CriteriaEric V Li, Eman E Ahmed, Mohamed E Ahmed, et al.
Pageof 1